<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-124343</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Cigarrán, S</dc:creator>
<dc:creator>Barril, G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Nefrologia;21(5): 510-511, sept.-oct. 2001. tab</dc:source>
<dc:identifier>ibc-124343</dc:identifier>
<dc:title xml:lang="es">Papel de la ferroterapia en la optimización del uso de la eritropoyetina (EPO) en pacientes en hemodiálisis (HD)</dc:title>
<dc:subject>^d7668^s22073</dc:subject>
<dc:subject>^d29387^s22073</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d32369^s22067</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d28630</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d32369^s22027</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d29407^s22020</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:type>article</dc:type>
<dc:date>200110</dc:date>
</metadata>
</record>
</ibecs-document>
